UniProt ID | CSN4_HUMAN | |
---|---|---|
UniProt AC | Q9BT78 | |
Protein Name | COP9 signalosome complex subunit 4 | |
Gene Name | COPS4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 406 | |
Subcellular Localization | Cytoplasm. Nucleus. Cytoplasmic vesicle, secretory vesicle, synaptic vesicle. | |
Protein Description | Component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. Also involved in the deneddylation of non-cullin subunits such as STON2. The complex is also involved in phosphorylation of p53/TP53, c-jun/JUN, IkappaBalpha/NFKBIA, ITPK1, IRF8/ICSBP and SNAPIN, possibly via its association with CK2 and PKD kinases. CSN-dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively.. | |
Protein Sequence | MAAAVRQDLAQLMNSSGSHKDLAGKYRQILEKAIQLSGAEQLEALKAFVEAMVNENVSLVISRQLLTDFCTHLPNLPDSTAKEIYHFTLEKIQPRVISFEEQVASIRQHLASIYEKEEDWRNAAQVLVGIPLETGQKQYNVDYKLETYLKIARLYLEDDDPVQAEAYINRASLLQNESTNEQLQIHYKVCYARVLDYRRKFIEAAQRYNELSYKTIVHESERLEALKHALHCTILASAGQQRSRMLATLFKDERCQQLAAYGILEKMYLDRIIRGNQLQEFAAMLMPHQKATTADGSSILDRAVIEHNLLSASKLYNNITFEELGALLEIPAAKAEKIASQMITEGRMNGFIDQIDGIVHFETREALPTWDKQIQSLCFQVNNLLEKISQTAPEWTAQAMEAQMAQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAAVRQDL ------CCHHHHHHH | 12.25 | 19413330 | |
16 | Phosphorylation | LAQLMNSSGSHKDLA HHHHHCCCCCCHHHH | 39.03 | 24719451 | |
20 | Ubiquitination | MNSSGSHKDLAGKYR HCCCCCCHHHHHHHH | 57.02 | 21890473 | |
20 | Ubiquitination | MNSSGSHKDLAGKYR HCCCCCCHHHHHHHH | 57.02 | 21890473 | |
25 | Acetylation | SHKDLAGKYRQILEK CCHHHHHHHHHHHHH | 31.49 | 19608861 | |
25 | Malonylation | SHKDLAGKYRQILEK CCHHHHHHHHHHHHH | 31.49 | 26320211 | |
25 | 2-Hydroxyisobutyrylation | SHKDLAGKYRQILEK CCHHHHHHHHHHHHH | 31.49 | - | |
25 | Ubiquitination | SHKDLAGKYRQILEK CCHHHHHHHHHHHHH | 31.49 | 19608861 | |
37 | Phosphorylation | LEKAIQLSGAEQLEA HHHHHHHCCHHHHHH | 21.41 | 28348404 | |
85 | Phosphorylation | DSTAKEIYHFTLEKI CCCHHHHHHHHHHHH | 7.62 | - | |
112 | Phosphorylation | SIRQHLASIYEKEED HHHHHHHHHHHCHHH | 31.87 | 20068231 | |
114 | Phosphorylation | RQHLASIYEKEEDWR HHHHHHHHHCHHHHH | 20.60 | 20068231 | |
116 | Ubiquitination | HLASIYEKEEDWRNA HHHHHHHCHHHHHHH | 49.81 | - | |
137 | Ubiquitination | IPLETGQKQYNVDYK CCCCCCCCEECCCHH | 56.97 | - | |
139 | Phosphorylation | LETGQKQYNVDYKLE CCCCCCEECCCHHHH | 24.96 | - | |
150 | Ubiquitination | YKLETYLKIARLYLE HHHHHHHHHHHHHCC | 24.73 | - | |
200 | Acetylation | RVLDYRRKFIEAAQR HHHHHHHHHHHHHHH | 41.52 | 25953088 | |
200 | Ubiquitination | RVLDYRRKFIEAAQR HHHHHHHHHHHHHHH | 41.52 | - | |
214 | Ubiquitination | RYNELSYKTIVHESE HHHHCCHHEEECHHH | 28.53 | - | |
227 | Ubiquitination | SERLEALKHALHCTI HHHHHHHHHHHHHHH | 33.60 | - | |
251 | Acetylation | RMLATLFKDERCQQL HHHHHHHCCHHHHHH | 62.89 | 26051181 | |
251 | 2-Hydroxyisobutyrylation | RMLATLFKDERCQQL HHHHHHHCCHHHHHH | 62.89 | - | |
251 | Ubiquitination | RMLATLFKDERCQQL HHHHHHHCCHHHHHH | 62.89 | - | |
266 | Ubiquitination | AAYGILEKMYLDRII HHHHHHHHHHHHHHH | 29.42 | - | |
268 | Phosphorylation | YGILEKMYLDRIIRG HHHHHHHHHHHHHCC | 19.27 | 22817900 | |
271 | Methylation | LEKMYLDRIIRGNQL HHHHHHHHHHCCCCH | 24.52 | - | |
290 | Ubiquitination | AMLMPHQKATTADGS HHHCCCCCCCCCCCC | 44.67 | - | |
298 | Phosphorylation | ATTADGSSILDRAVI CCCCCCCCHHHHHHH | 32.47 | 26437602 | |
311 | Phosphorylation | VIEHNLLSASKLYNN HHHCCCCCHHHHHCC | 33.39 | 23312004 | |
334 | Ubiquitination | LLEIPAAKAEKIASQ HHHCHHHHHHHHHHH | 60.22 | - | |
337 | Acetylation | IPAAKAEKIASQMIT CHHHHHHHHHHHHHH | 48.72 | 25953088 | |
337 | Ubiquitination | IPAAKAEKIASQMIT CHHHHHHHHHHHHHH | 48.72 | - | |
340 | Phosphorylation | AKAEKIASQMITEGR HHHHHHHHHHHHHCC | 24.61 | 30622161 | |
344 | Phosphorylation | KIASQMITEGRMNGF HHHHHHHHHCCCCCH | 27.35 | 20068231 | |
372 | Ubiquitination | EALPTWDKQIQSLCF CCCCCCHHHHHHHHH | 40.64 | - | |
389 | Phosphorylation | NNLLEKISQTAPEWT HHHHHHHHHCCHHHH | 32.33 | 18491316 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CSN4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CSN4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CSN4_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Characterization of the human COP9 signalosome complex using affinitypurification and mass spectrometry."; Fang L., Wang X., Yamoah K., Chen P.L., Pan Z.Q., Huang L.; J. Proteome Res. 7:4914-4925(2008). Cited for: IDENTIFICATION IN THE CSN COMPLEX, CLEAVAGE OF INITIATOR METHIONINE,AND ACETYLATION AT ALA-2. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-25, AND MASS SPECTROMETRY. |